Nanosuspensions: a promising drug delivery strategy

The Journal of Pharmacy and Pharmacology
V B PatravaleR M Kulkarni

Abstract

Nanosuspensions have emerged as a promising strategy for the efficient delivery of hydrophobic drugs because of their versatile features and unique advantages. Techniques such as media milling and high-pressure homogenization have been used commercially for producing nanosuspensions. Recently, the engineering of nanosuspensions employing emulsions and microemulsions as templates has been addressed in the literature. The unique features of nanosuspensions have enabled their use in various dosage forms, including specialized delivery systems such as mucoadhesive hydrogels. Rapid strides have been made in the delivery of nanosuspensions by parenteral, peroral, ocular and pulmonary routes. Currently, efforts are being directed to extending their applications in site-specific drug delivery.

References

Jul 1, 1984·Journal of Pharmaceutical Sciences·B W Müller, R H Müller
Oct 1, 1993·Journal of Pharmaceutical Sciences·M J SkibicS W Baertschi
Dec 1, 1995·Trends in Biotechnology·G Gregoriadis
Oct 1, 1996·Journal of Pharmaceutical Sciences·T Loftsson, M E Brewster
May 1, 1997·Pharmaceutical Research·V J Stella, R A Rajewski
Jan 1, 1997·Drugs·T M Allen
Nov 13, 1998·Journal of Pharmaceutical Sciences·U SchroederB A Sabel
May 14, 1999·Pharmaceutical Science & Technology Today·A G Floyd
Jun 17, 1999·International Journal of Pharmaceutics·K M Park, C K Kim
Oct 9, 1999·Journal of Pharmaceutical Sciences·T KristmundsdóttirH Thormar
Oct 16, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·L Z BenetV J Wacher
Feb 17, 2000·International Journal of Pharmaceutics·H Sah
Mar 4, 2000·International Journal of Pharmaceutics·M J GrauR H Müller
Mar 16, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·S LooareesuwanJ D Chulay
Mar 29, 2000·Journal of Pharmaceutical Sciences·B J Aungst
Jun 6, 2000·Advanced Drug Delivery Reviews·M C Woodle
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C Leuner, J Dressman
Aug 5, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·C E SomaP Couvreur
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C W Pouton
Dec 6, 2000·Advanced Drug Delivery Reviews·M Nakano
Dec 6, 2000·Advanced Drug Delivery Reviews·M J Lawrence, G D Rees
Feb 13, 2001·International Journal of Pharmaceutics·S P VyasV Sihorkar
Mar 17, 2001·Advanced Drug Delivery Reviews·J Kreuter
Apr 3, 2001·International Journal of Pharmaceutics·K P Krause, R H Müller
May 5, 2001·International Journal of Pharmaceutics·G J VergoteJ P Remon
May 17, 2001·Antimicrobial Agents and Chemotherapy·N SchölerO Liesenfeld
Sep 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M TrottaS Morel
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·Bertrand Dupont
Mar 9, 2002·Pharmaceutical Research·Claudia Jacobs, Rainer Helmut Müller
Apr 17, 2002·International Journal of Pharmaceutics·R H Müller, C Jacobs
May 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kohsaku KawakamiKazuyoshi Masuda
Jul 13, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Rosario PignatelloGiovanni Puglisi
Aug 23, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jörg Breitenbach

❮ Previous
Next ❯

Citations

Jun 5, 2008·Pharmaceutical Research·John C ButcherPuneet Sharma
Jun 4, 2013·Biomaterials·Abhijit A Date, Christopher J Destache
Apr 23, 2013·Colloids and Surfaces. B, Biointerfaces·Pradum Pundlikrao IgeSurendra G Gattani
Jun 25, 2009·Physical Chemistry Chemical Physics : PCCP·Pieter SaveynPaul Van der Meeren
Sep 29, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Khosro AdibkiaAli Nokhodchi
Aug 29, 2013·Journal of Biomedical Nanotechnology·Vuk Uskoković
Jan 17, 2009·AAPS PharmSciTech·Bernard Van EerdenbrughGuy Van den Mooter
Jul 8, 2010·Chemical & Pharmaceutical Bulletin·Yuan GaoJianjun Zhang
Jul 29, 2011·International Journal of Nanomedicine·Yonglu WangPing Wei
Jul 18, 2012·International Journal of Nanomedicine·Lili WangNa Zhang
May 4, 2013·International Journal of Nanomedicine·Fuxia DongWei Wu
Aug 27, 2013·International Journal of Nanomedicine·Peng-Fei YueHai-Long Yuan
Feb 5, 2014·International Journal of Nanomedicine·Mingrong ChengZhiping Zhang
Aug 29, 2007·International Journal of Nanomedicine·Li-Jiuan Shen, Fe-Lin Lin Wu
Jun 28, 2014·International Journal of Nanomedicine·Ibrahim ElsayedAhmed Hassen Elshafeey
Jul 28, 2012·Therapeutic Delivery·Gareth R WilliamsChristopher J Branford-White
Oct 17, 2012·International Journal of Pharmaceutical Investigation·Swati SareenLincy Joseph
Aug 25, 2007·Nanomedicine·Raj Bawa
Jan 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ying LuMichael Sturek
Jul 26, 2012·ISRN Pharmaceutics·Ketan T SavjaniJignasa K Savjani
Nov 8, 2013·European Journal of Drug Metabolism and Pharmacokinetics·Bhanu P Sahu, Malay K Das
Jun 13, 2014·AAPS PharmSciTech·Sanket M ShahManeesh J Nerurkar
Mar 20, 2015·Drug Delivery and Translational Research·Anju MalkaniDarshana Hegde
Mar 19, 2014·Ultrasonics Sonochemistry·John R G SanderKenneth S Suslick
Sep 1, 2014·International Journal of Pharmaceutics·Jun ZhangZafar Iqbal
Sep 1, 2014·Urolithiasis·Fatemeh Abbasi GhaeniHossein Hosseinzadeh
Oct 1, 2013·Drug Delivery and Translational Research·Vividha DhapteVarsha Pokharkar
Dec 24, 2011·Journal of Drug Targeting·Yue LiuQiang Zhang
Nov 19, 2011·Drug Development and Industrial Pharmacy·Cheng-Dong HouHong Zhao
Feb 13, 2014·Drug Development and Industrial Pharmacy·Sai H S BodduRose Jung
Mar 26, 2008·Drug Development and Industrial Pharmacy·Jiraporn ChingunpitakKeiji Yamamoto
Feb 26, 2009·Expert Opinion on Drug Delivery·Slavomira Doktorovova, Eliana B Souto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Drug Discovery
Barrett E Rabinow
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Cornelia M Keck, Rainer H Müller
© 2022 Meta ULC. All rights reserved